Navigation Links
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Date:6/14/2010

SAN DIEGO, June 14 /PRNewswire/ -- aTyr Pharma, Inc. today announced that Catharine E. Johnson, Ph.D. has recently joined the company as its Senior Vice President of Business Development.  Dr. Johnson's extensive biotechnology industry experience will help to advance aTyr Pharma's portfolio of resectin-based therapeutics. Resectins are a novel class of endogenous human proteins derived from aminoacyl tRNA synthetases, and have activities relevant to multiple disease areas, including autoimmunity, inflammation, and blood disorders. The privately held biotech was co-founded by Dr. Xianglei Yang and Dr. Paul Schimmel, a leading aminoacyl tRNA synthetase scientist and serial entrepreneur in the biotech sector.

Dr. Johnson brings a broad range of strategy and business development experience to aTyr. She was most recently Vice President, Corporate Development at Momenta Pharmaceuticals, Inc. (MNTA), where she managed corporate strategy and negotiated transactions related to the company's proprietary technology platform and product portfolio, including significant transactions with Novartis AG/Sandoz.  Dr. Johnson was previously a Principal at Atlas Venture, where she was responsible for new biotech investments and the management of portfolio companies.  She also served as head of business development at Regeneron Pharmaceuticals, where she was responsible for new business initiatives, strategic partnering, and alliance management, and her activities included key transactions with Novartis, Aventis, and Serono.  Dr. Johnson received her Doctorate from the Johns Hopkins School of Medicine's Department of Biological Chemistry.

"Catharine is an important addition to our senior management team,"
'/>"/>

SOURCE aTyr Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmatech Oncology to Present at 46th Annual DIA Meeting
2. Anthera Pharmaceuticals Promotes Colin Hislop, M.D., to Chief Medical Officer
3. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
4. OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference
5. Amylin Pharmaceuticals to Present at the 2010 Jefferies Global Life Sciences Conference
6. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
7. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
8. Diplomat Specialty Pharmacy Launches New Navigator Health Services to Meet Next Generation Needs of Specialty Pharmacy Industry
9. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
10. Onyx Pharmaceuticals Initiates Phase 1 Study of Oral Proteasome Inhibitor in Advanced Solid Tumors
11. University of Maryland School of Pharmacy Adopts BioSoteria's eLearning Drug Safety Courses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015  US-Australian drug discovery company, Novogen, ... of Understanding with the Feinstein Institute for Medical ... to collaborate with the objective of ... The collaboration brings together the drug discovery expertise ... of the Feinstein Institute in neurosciences and oncology. ...
(Date:4/16/2015)... Carolina (PRWEB) April 17, 2015 ... steam system services, released their newly designed, state-of-the-art ... The customer facing website effectively promotes the Spirax ... , All the information that a site visitor ... system services, company capabilities, industries serviced, the latest ...
(Date:4/16/2015)... FL (PRWEB) April 16, 2015 ... cap distribution and physician network in Europe and ... company has appointed Fernando Bermúdez, former Business Development ... , An industry veteran, Mr. Bermúdez’s professional achievements ... 75% in Spain, while also penetrating the Portuguese ...
(Date:4/16/2015)... Ohio (PRWEB) April 16, 2015 ... Index, overexertion involving an outside source was ranked ... This includes injuries related to lifting, pushing, pulling, ... billion in direct costs. The David Round Company ... is committed to working hard to develop and ...
Breaking Biology Technology:Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6Spirax Sarco website has a new look 2Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2
... Silence Therapeutics plc (AIM: SLN) ("Silence" ... (RNAi) therapeutics company, today announces that application has been sought ... Shares") to be admitted to trading on AIM. The new ... agreement with Dr. Philip Haworth, former Chief Executive Officer of ...
... computational tasks -- may have applications in areas outside ... researcher and his collaborators. Working at the interface ... in Pitt,s Department of Physics and Astronomy in the ... his colleagues report their findings in a paper published ...
... Dec. 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: ... largest umbilical cord blood banking operator in China, today announced ... held on December 19, 2011, in Hong Kong. ... Ms. Ting Zheng and Dr. Yungang (Ken) Lu to serve ...
Cached Biology Technology:Silence Therapeutics Additional Listing 2Silence Therapeutics Additional Listing 3Quantum computing has applications in magnetic imaging, say Pitt researchers 2China Cord Blood Corporation Announces Results of 2011 Annual General Meeting 2
(Date:4/2/2015)... 2, 2015 According to preliminary ... to somewhat higher than 125 MSEK. This exceeds the ... 2014 that revenues for Q1 2015 would be in ... for Q4 2014. The operating result for the first ... complete interim report will as previously communicated be published ...
(Date:3/31/2015)... YORK , March 31, 2015   Guidepoint ... the launch of the Post-Surgical Pain Management TRACKER, part ... products tracking usage trends in the medical device and ... access to data including treatment volumes, market share, and ... the pain associated with joint surgery. The ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... critical security-authentication needs, today announced the beginning of shipments ... solution. The company, based in ... the three-day Connect:ID Expo, which began here today at ... said version 2.0 of its SDK boosts the accuracy ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... The National Physical Laboratory (NPL) is hosting a ... into ,Measuring the Impossible,. The conference runs until ... The Measuring the Impossible, Network (MINET) shares research ... ways to measure complex phenomena that are dependent ...
... PARIS, November 12 Oberthur Technologies ... solutions to the Identity,market - has obtained several common ... Electronic passports, Governmental,Multi-application cards and European Citizen Cards. , ... Module ID-One ePass version 2.1 is ...
... counter-terrorist strategies and highlighting new and developing technologies to ... NJIT on Nov. 14, 2009, from 8:30 a.m. to ... Chapter of the Marine Corps Reserve Association, has invited ... ranging from cyber-security to protecting transportation venues. , ...
Cached Biology News:Researchers gather in the UK to 'measure the impossible' 2Oberthur Technologies: Major Security Certifications for the Identity Product Range 2Oberthur Technologies: Major Security Certifications for the Identity Product Range 3
... Many modifications of Eagle's medium ... original formulation. The most widely ... Eagle's,Medium. DME is a modification ... [MEM] that contains a higher ...
... fixative useful for routine procedures. Hollandes contains ... and will decalcify small bone specimens. Tissue ... stained successfully with most stains, and the ... blood cell membranes and cosinophil and endocrine ...
... Shimadzus GCMS-QP2010s Gas Chromatograph/Mass Spectrometer, ... of the GCMS-QP2010 Plus, offers high ... with an excellent performance-to-cost ratio. Like ... patented constant linear velocity for optimum ...
... uniquely combines a single-channel sample processing head, ... bulk reagent dispenser all in one compact, ... disposable pipette tips, the Precision XS autoclavable ... is available for transferring larger volumes. Intuitive ...
Biology Products: